The company was founded in December 2012 and is an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. With excellent innovative drug discovery capabilities, advanced biotechnology research and development, large-scale production technology throughout the entire industry chain, and a combination of drugs under development with great market potential, the company has great potential in tumor immunotherapy, as well as treatment of autoimmune diseases, chronic metabolic diseases, neurological diseases, and infectious diseases. The company's main business is the discovery and development of innovative drugs, as well as clinical research and commercialization on a global scale. The company's main products are mainly biological products innovated at the source and independently developed. Corporate honors: “Zhangjiang Star” Leading Enterprise in the Zhangjiang National Independent Innovation Demonstration Zone”, “Leading Power: High-Quality Chinese Pharmaceutical Development Achievement Enterprise (2022)”, “High Quality Development of the Big Health Industry - Excellent Case of Informatization”, etc.